Today’s editionWed 18 Nov 2026
AI Compass
WeeklyArchiveAbout

Company dossier

Isomorphic Labs

AI Compass tracks 1 confirmed launch from Isomorphic Labs in research (17 Nov 2026), verified against primary official documentation and release notes.

1Launch

1Category

Official domain
isomorphiclabs.com
Latest coverage
17 Nov 2026
Focus areas
Research 1

Peer labs in Research: OpenAI (51) · Anthropic (43) · Google (36) · Perplexity (13) · Google DeepMind (11) · Meta (9)

Isomorphic Labs raises $5B Series C to scale its AI drug design engine

Co-led on 17 November 2026 by Greenoaks and Sequoia Capital with Andreessen Horowitz, Alphabet, Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund.

ResearchStory 11 of the day

60-second takeaway: Isomorphic Labs raises a $5 billion Series C round co-led by Greenoaks and Sequoia Capital to scale its IsoDDE drug design engine towards clinical trials.

Why it matters: Raising $5 billion gives Isomorphic Labs sovereign-biotech capital to fund wet-lab validation and human clinical trials on its own internal drug pipeline beyond pharma partnerships.

Financing round and size
$5 billion Series C announced on 17 November 2026 (post-money valuation undisclosed)
Co-lead and new investors
Co-led by Greenoaks and Sequoia Capital, joined by Andreessen Horowitz (a16z) and Alphabet
Returning investors
Thrive Capital, MGX, GV, CapitalG, Temasek and the UK Sovereign AI Fund